Jayendra Patel's research topics

Jayendra Patel

Concepts (71)

Back to Profile

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name	Number of Publications	Most Recent Publication	Publications by All Authors	Concept Score	Why?
Antipsychotic Agents	4	2009	307	0.380	Why?
Metabolome	1	2009	36	0.300	Why?
Mental Disorders	1	2009	824	0.170	Why?
Schizophrenia	3	2012	280	0.170	Why?
Schizophrenic Psychology	2	2012	75	0.140	Why?
Psychotic Disorders	2	2012	164	0.130	Why?
Psychiatric Status Rating Scales	4	2013	393	0.120	Why?
Double-Blind Method	4	2012	749	0.110	Why?
Antidepressive Agents	2	2013	230	0.100	Why?
Memantine	1	2013	23	0.100	Why?
Remedial Teaching	1	2012	2	0.090	Why?
Computer-Assisted Instruction	1	2012	81	0.090	Why?
Cognition Disorders	1	2012	223	0.080	Why?
Metabolic Diseases	1	2009	59	0.070	Why?
Body Mass Index	2	2009	888	0.070	Why?
Body Weight	1	2009	381	0.070	Why?
Dose-Response Relationship, Drug	1	2009	880	0.060	Why?
Depression	1	2013	916	0.060	Why?
Sex Factors	1	2009	997	0.060	Why?
Follow-Up Studies	2	2009	2510	0.060	Why?
Haloperidol	1	2005	16	0.060	Why?
Event-Related Potentials, P300	1	2005	3	0.060	Why?
Clozapine	1	2005	32	0.060	Why?
Adult	7	2013	17416	0.050	Why?
Time Factors	2	2009	3788	0.050	Why?
Metabolic Syndrome	1	2005	147	0.050	Why?
Bipolar Disorder	1	2006	249	0.050	Why?
Adolescent	2	2009	6377	0.040	Why?
Male	7	2013	31081	0.040	Why?
Female	7	2013	34130	0.040	Why?
Drug Therapy, Combination	2	2013	473	0.040	Why?
Young Adult	1	2009	4830	0.040	Why?
Quality of Life	1	2005	1270	0.030	Why?
Treatment Outcome	3	2013	5822	0.030	Why?
Humans	7	2013	65551	0.030	Why?
Excitatory Amino Acid Agonists	1	2013	19	0.030	Why?
Drug Synergism	1	2013	146	0.020	Why?
Diagnostic and Statistical Manual of Mental Disorders	1	2013	121	0.020	Why?
Receptors, N-Methyl-D-Aspartate	1	2013	90	0.020	Why?
Drug Monitoring	1	2013	205	0.020	Why?
Inservice Training	1	2012	87	0.020	Why?
Evidence-Based Practice	1	2012	85	0.020	Why?
Neuropsychological Tests	1	2012	410	0.020	Why?
Feasibility Studies	1	2012	582	0.020	Why?
Pilot Projects	1	2012	1018	0.020	Why?
Anthropometry	1	2005	87	0.010	Why?
Cholesterol, HDL	1	2005	72	0.010	Why?
Fasting	1	2005	52	0.010	Why?
Chlorpromazine	1	2005	8	0.010	Why?
Psychotherapy	1	2006	102	0.010	Why?
Combined Modality Therapy	1	2006	375	0.010	Why?
Benzodiazepines	1	2005	106	0.010	Why?
Pain Measurement	1	2005	344	0.010	Why?
Anxiety Disorders	1	2006	201	0.010	Why?
Recurrence	1	2006	661	0.010	Why?
Triglycerides	1	2005	250	0.010	Why?
Depressive Disorder	1	2006	288	0.010	Why?
Cerebral Cortex	1	2005	271	0.010	Why?
Hypoglycemic Agents	1	2005	224	0.010	Why?
Blood Pressure	1	2005	526	0.010	Why?
Blood Glucose	1	2005	492	0.010	Why?
Pain	1	2005	403	0.010	Why?
Comorbidity	1	2006	1126	0.010	Why?
Longitudinal Studies	1	2006	1287	0.010	Why?
Insulin	1	2005	694	0.010	Why?
Middle Aged	2	2012	18276	0.010	Why?
Prevalence	1	2005	1441	0.010	Why?
Prognosis	1	2006	1793	0.010	Why?
Disease Progression	1	2005	1217	0.010	Why?
Prospective Studies	1	2006	3355	0.010	Why?
Risk Factors	1	2006	5441	0.010	Why?

Patel's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (71)

Explore

Co-Authors (2)

Explore

Similar People (60)

Explore

Same Department

Explore

Physical Neighbors